{"id":"https://openalex.org/W2172015659","doi":"https://doi.org/10.15252/emmm.201404271","title":"Metabolic and hypoxic adaptation to anti\u2010angiogenic therapy: a target for induced essentiality","display_name":"Metabolic and hypoxic adaptation to anti\u2010angiogenic therapy: a target for induced essentiality","alternate_titles":[],"publication_year":2015,"publication_date":"2015-02-19","ids":{"openalex":"https://openalex.org/W2172015659","doi":"https://doi.org/10.15252/emmm.201404271","mag":"2172015659","pmid":"https://pubmed.ncbi.nlm.nih.gov/25700172","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4403040"},"language":"en","primary_location":{"id":"doi:10.15252/emmm.201404271","doi":"https://doi.org/10.15252/emmm.201404271","is_oa":true,"landing_page_url":"https://doi.org/10.15252/emmm.201404271","pdf_url":null,"source":{"id":"https://openalex.org/S163075119","display_name":"EMBO Molecular Medicine","issn_l":"1757-4676","issn":["1757-4676","1757-4684"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EMBO Molecular Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2172015659"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.15252/emmm.201404271","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046536351","display_name":"Alan McIntyre","orcid":"https://orcid.org/0000-0002-4791-7292","observed_orcids":["https://orcid.org/0000-0002-4791-7292"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210110594","display_name":"MRC Weatherall Institute of Molecular Medicine","ror":"https://ror.org/01q496a73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alan McIntyre","raw_affiliation_strings":["Hypoxia and angiogenesis Group, Department of Oncology Weatherall Institute of Molecular Medicine University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hypoxia and angiogenesis Group, Department of Oncology Weatherall Institute of Molecular Medicine University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210110594"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079633934","display_name":"Adrian Llewellyn Harris","orcid":"https://orcid.org/0000-0003-1376-8409","observed_orcids":["https://orcid.org/0000-0003-1376-8409"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210110594","display_name":"MRC Weatherall Institute of Molecular Medicine","ror":"https://ror.org/01q496a73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Adrian L Harris","raw_affiliation_strings":["Hypoxia and angiogenesis Group, Department of Oncology Weatherall Institute of Molecular Medicine University of Oxford, Oxford, UK aharris.lab@imm.ox.ac.uk","Hypoxia and angiogenesis Group Department of Oncology Weatherall Institute of Molecular Medicine University of Oxford Oxford UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hypoxia and angiogenesis Group, Department of Oncology Weatherall Institute of Molecular Medicine University of Oxford, Oxford, UK aharris.lab@imm.ox.ac.uk","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210110594"]},{"raw_affiliation_string":"Hypoxia and angiogenesis Group Department of Oncology Weatherall Institute of Molecular Medicine University of Oxford Oxford UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210110594"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5079633934"],"corresponding_institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210110594"],"apc_list":{"value":7990,"currency":"USD","value_usd":7990},"apc_paid":{"value":7990,"currency":"USD","value_usd":7990},"fwci":2.5946,"has_fulltext":true,"cited_by_count":198,"citation_normalized_percentile":{"value":0.93261317,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"7","issue":"4","first_page":"368","last_page":"379"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.6478999853134155,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.6478999853134155,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.3483999967575073,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.9959999918937683},{"id":"https://openalex.org/keywords/vegf-signaling","display_name":"VEGF signaling","score":0.593999981880188},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.8149999976158142},{"id":"https://openalex.org/keywords/hypoxia-inducible-factor","display_name":"hypoxia-inducible factor","score":0.8659999966621399},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5950000286102295},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.9200000166893005},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6669999957084656},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9309999942779541},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.9610000252723694},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.45500001311302185}],"concepts":[{"id":"https://openalex.org/C7836513","wikidata":"https://www.wikidata.org/wiki/Q1641506","display_name":"Hypoxia (environmental)","level":3,"score":0.6478736996650696},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.600053071975708},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.5509275794029236},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5376409888267517},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.5136496424674988},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5035261511802673},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.48243770003318787},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.392846941947937},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.372029185295105},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.34211722016334534},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2896563410758972},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.11800417304039001},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.07222500443458557},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C540031477","wikidata":"https://www.wikidata.org/wiki/Q629","display_name":"Oxygen","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D015687","descriptor_name":"Cell Hypoxia","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051792","descriptor_name":"Basic Helix-Loop-Helix Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051792","descriptor_name":"Basic Helix-Loop-Helix Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.15252/emmm.201404271","doi":"https://doi.org/10.15252/emmm.201404271","is_oa":true,"landing_page_url":"https://doi.org/10.15252/emmm.201404271","pdf_url":null,"source":{"id":"https://openalex.org/S163075119","display_name":"EMBO Molecular Medicine","issn_l":"1757-4676","issn":["1757-4676","1757-4684"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EMBO Molecular Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4403040","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4403040/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4403040/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EMBO Mol Med","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:3369390","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4403040","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:25700172","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25700172","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EMBO molecular medicine","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:2acbd75720b84498a2a697c584a68456","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/2acbd75720b84498a2a697c584a68456","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"EMBO Molecular Medicine, Vol 7, Iss 4, Pp 368-379 (2015)","raw_type":"article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.685.3342","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.685.3342","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://embomolmed.embopress.org/content/embomm/early/2015/02/19/emmm.201404271.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.15252/emmm.201404271","doi":"https://doi.org/10.15252/emmm.201404271","is_oa":true,"landing_page_url":"https://doi.org/10.15252/emmm.201404271","pdf_url":null,"source":{"id":"https://openalex.org/S163075119","display_name":"EMBO Molecular Medicine","issn_l":"1757-4676","issn":["1757-4676","1757-4684"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EMBO Molecular Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1425849753","display_name":null,"funder_award_id":"11359","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G5920461105","display_name":null,"funder_award_id":"16466","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G7499079676","display_name":"NIHR Senior Investigator Award","funder_award_id":"NF-SI-0611-10163","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G8651018663","display_name":null,"funder_award_id":"18974","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"}],"funders":[{"id":"https://openalex.org/F4320306260","display_name":"Breast Cancer Research Foundation","ror":"https://ror.org/0348ff195"},{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2172015659.pdf","grobid_xml":"https://content.openalex.org/works/W2172015659.grobid-xml"},"referenced_works_count":89,"referenced_works":["https://openalex.org/W161777538","https://openalex.org/W1963955463","https://openalex.org/W1968140809","https://openalex.org/W1971176613","https://openalex.org/W1975701262","https://openalex.org/W1976767579","https://openalex.org/W1977534471","https://openalex.org/W1978139448","https://openalex.org/W1981233558","https://openalex.org/W1986912321","https://openalex.org/W1989402742","https://openalex.org/W1991429659","https://openalex.org/W1993412993","https://openalex.org/W1995012315","https://openalex.org/W1995200161","https://openalex.org/W1995229256","https://openalex.org/W2000016962","https://openalex.org/W2000542942","https://openalex.org/W2003112634","https://openalex.org/W2007979842","https://openalex.org/W2013197178","https://openalex.org/W2014125735","https://openalex.org/W2015012139","https://openalex.org/W2015561372","https://openalex.org/W2016678911","https://openalex.org/W2017322644","https://openalex.org/W2020304503","https://openalex.org/W2026996188","https://openalex.org/W2029237663","https://openalex.org/W2029862112","https://openalex.org/W2034269086","https://openalex.org/W2036941876","https://openalex.org/W2040044819","https://openalex.org/W2043044442","https://openalex.org/W2045389113","https://openalex.org/W2046736738","https://openalex.org/W2047521631","https://openalex.org/W2050086663","https://openalex.org/W2054728198","https://openalex.org/W2057001750","https://openalex.org/W2059099021","https://openalex.org/W2060473754","https://openalex.org/W2063620817","https://openalex.org/W2065925372","https://openalex.org/W2068283599","https://openalex.org/W2069518226","https://openalex.org/W2069526715","https://openalex.org/W2072549244","https://openalex.org/W2078659604","https://openalex.org/W2081596239","https://openalex.org/W2088441277","https://openalex.org/W2091516108","https://openalex.org/W2094518946","https://openalex.org/W2096252516","https://openalex.org/W2096823131","https://openalex.org/W2097764517","https://openalex.org/W2101332957","https://openalex.org/W2104032744","https://openalex.org/W2106223802","https://openalex.org/W2107975811","https://openalex.org/W2109134893","https://openalex.org/W2117692326","https://openalex.org/W2118185746","https://openalex.org/W2124396025","https://openalex.org/W2129512401","https://openalex.org/W2134431790","https://openalex.org/W2136374331","https://openalex.org/W2137465719","https://openalex.org/W2141574380","https://openalex.org/W2141759479","https://openalex.org/W2144574890","https://openalex.org/W2144893998","https://openalex.org/W2146628652","https://openalex.org/W2148532787","https://openalex.org/W2149898004","https://openalex.org/W2149902856","https://openalex.org/W2150589406","https://openalex.org/W2154152918","https://openalex.org/W2154816100","https://openalex.org/W2155332617","https://openalex.org/W2157769714","https://openalex.org/W2161531166","https://openalex.org/W2162527266","https://openalex.org/W2163038498","https://openalex.org/W2169633433","https://openalex.org/W2169691707","https://openalex.org/W2170633837","https://openalex.org/W2219898633","https://openalex.org/W2334499767"],"related_works":["https://openalex.org/W2077238331","https://openalex.org/W4234258522","https://openalex.org/W7067701507","https://openalex.org/W14551090","https://openalex.org/W2998918402","https://openalex.org/W4247193766","https://openalex.org/W2025539366","https://openalex.org/W2054770163","https://openalex.org/W2137090229"],"abstract_inverted_index":{"Anti-angiogenic":[0],"therapy":[1,46,191],"has":[2,12,65],"increased":[3,105],"the":[4,55,61,70,73,90,137,141,158,168],"progression-free":[5],"survival":[6],"of":[7,42,115,144,160],"many":[8],"cancer":[9,22],"patients":[10],"but":[11],"had":[13],"little":[14],"effect":[15],"on":[16],"overall":[17],"survival,":[18],"even":[19],"in":[20,79,157,175,187],"colon":[21],"(average":[23],"6-8":[24],"weeks)":[25],"due":[26],"to":[27,44,53,82],"resistance.":[28],"The":[29,85],"current":[30],"licensed":[31],"targeted":[32],"therapies":[33],"all":[34],"inhibit":[35],"VEGF":[36],"signalling":[37],"(Table":[38],"1).":[39],"Many":[40],"mechanisms":[41],"resistance":[43],"anti-VEGF":[45],"have":[47,121,129,181],"been":[48,66,130],"identified":[49],"that":[50,72,180],"enable":[51],"cancers":[52],"bypass":[54],"angiogenic":[56],"blockade.":[57],"In":[58],"addition,":[59],"over":[60],"last":[62],"decade,":[63],"there":[64],"increasing":[67],"evidence":[68],"for":[69,166,183],"role":[71],"hypoxic":[74,86,117,169],"and":[75,101,107,118,125,136,177],"metabolic":[76,100,119],"responses":[77],"play":[78],"tumour":[80,87,116,170],"adaptation":[81,120],"anti-angiogenic":[83,190],"therapy.":[84],"response,":[88],"through":[89],"transcription":[91],"factor":[92],"hypoxia-inducible":[93],"factors":[94],"(HIFs),":[95],"induces":[96],"major":[97],"gene":[98],"expression,":[99],"phenotypic":[102],"changes,":[103],"including":[104],"invasion":[106],"metastasis.":[108],"Pre-clinical":[109],"studies":[110,179],"combining":[111],"anti-angiogenics":[112],"with":[113,151,189],"inhibitors":[114],"shown":[122],"great":[123],"promise,":[124],"combination":[126,188],"clinical":[127,178],"trials":[128],"instigated.":[131],"Understanding":[132],"individual":[133],"patient":[134],"response":[135,138],"timing,":[139],"given":[140],"opposing":[142],"effects":[143],"vascular":[145],"normalisation":[146],"versus":[147],"reduced":[148],"perfusion":[149],"seen":[150],"anti-angiogenics,":[152],"provides":[153],"a":[154,193],"further":[155],"hurdle":[156],"paradigm":[159],"personalised":[161],"therapeutic":[162,195],"intervention.":[163],"Additional":[164],"approaches":[165],"targeting":[167],"microenvironment":[171],"are":[172],"being":[173],"investigated":[174],"pre-clinical":[176],"potential":[182],"producing":[184],"synthetic":[185],"lethality":[186],"as":[192],"future":[194],"strategy.":[196]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2172015659","counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":24},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":21},{"year":2018,"cited_by_count":25},{"year":2017,"cited_by_count":28},{"year":2016,"cited_by_count":24},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
